Januszewicz, W., Pilonis, N. D., Phillips, R., O'Donovan, M., Sawas, T., Katzka, D. A., . . . Di Pietro, M. (2021). ID: 3523652 P53 IMMUNOHISTOCHEMISTRY REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSES IN BARRETT'S ESOPHAGUS ASSESSMENT AND IMPROVES THE INTEROBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS. Gastrointestinal endoscopy, 93(6), AB288. https://doi.org/10.1016/j.gie.2021.03.603
Citácia podle Chicago (17th ed.)Januszewicz, Wladyslaw, et al. "ID: 3523652 P53 IMMUNOHISTOCHEMISTRY REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSES IN BARRETT'S ESOPHAGUS ASSESSMENT AND IMPROVES THE INTEROBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS." Gastrointestinal Endoscopy 93, no. 6 (2021): AB288. https://doi.org/10.1016/j.gie.2021.03.603.
Citácia podľa MLA (8th ed.)Januszewicz, Wladyslaw, et al. "ID: 3523652 P53 IMMUNOHISTOCHEMISTRY REDUCES THE RATE OF INDEFINITE FOR DYSPLASIA DIAGNOSES IN BARRETT'S ESOPHAGUS ASSESSMENT AND IMPROVES THE INTEROBSERVER AGREEMENT AMONG HISTOPATHOLOGISTS." Gastrointestinal Endoscopy, vol. 93, no. 6, 2021, p. AB288, https://doi.org/10.1016/j.gie.2021.03.603.